Bioinformatics Market to Grow Steadily Through 2032 - Market Insights, Competitive Landscape, and Forecast | DelveInsight

The global bioinformatics market is expected to witness robust growth through 2032, driven by the expanding applications of bioinformatics in genomics, drug discovery, personalized medicine, and clinical diagnostics. The integration of AI and machine learning with bioinformatics tools, increasing demand for genomic data analysis, and the surge in next-generation sequencing (NGS) projects are significantly contributing to market acceleration. Moreover, the growing focus on precision medicine and biological data management across academic, pharmaceutical, and biotechnology sectors is further fueling the demand for advanced bioinformatics platforms.

DelveInsight's Bioinformatics Market Insights report provides an in-depth evaluation of market dynamics, emerging trends, key growth drivers and challenges, competitive landscape, and company profiles. This comprehensive analysis equips stakeholders with valuable strategic insights to capitalize on opportunities in the evolving bioinformatics domain and drive innovation across healthcare and life sciences sectors.

Explore the latest trends and growth drivers in the bioinformatics market-download your sample report now https://www.delveinsight.com/report-store/bioinformatics-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=jpr

Key Takeaways from the Bioinformatics Market Report
• The global bioinformatics market was valued at USD 20.12 billion in 2023 and is projected to grow at a CAGR of 15.14% from 2025 to 2032, reaching USD 46.88 billion by 2032.
• As per DelveInsight estimates, North America is anticipated to dominate the global bioinformatics market during the forecast period.
• Notable bioinformatics companies such as Agilent Technologies, Biomax Informatics AG, DNANEXUS, INC., Thermo Fisher Scientific, Inc., Eurofins Scientific, QIAGEN N.V., Illumina Inc., NeoGenomics Laboratories, Rosalind Inc., Perkin Elmer, Inc., GENEWIZ, BGI Corporation, and several others are currently operating in the bioinformatics market.
• In June 2025, the FDA introduced "Elsa," a generative AI tool designed to enhance the efficiency of scientific reviews. Elsa assists in expediting clinical protocol reviews, summarizing adverse events, and streamlining scientific evaluations. It operates within a secure platform, ensuring confidentiality of sensitive internal documents.
• In October 2024, Dash Bio, a biotech-services startup founded by former Moderna executives, launched with the goal of accelerating drug development. The company utilizes robotics, AI, and software to automate the testing and analysis of clinical trial samples, aiming to expedite decision-making processes in clinical studies.
• In September 2024, the FDA granted 510(k) clearance to Cortechs.ai's NeuroQuant 5.0 software. This advanced AI-powered tool aids in the segmentation and quantification of MRI lesions associated with amyloid-related imaging abnormalities (ARIA) in patients undergoing anti-amyloid treatment for Alzheimer's disease.
• In September 2024, AstraZeneca entered into a collaboration with Immunai, investing $18 million to leverage Immunai's AI model of the immune system. This partnership aims to enhance cancer drug trials by improving efficiency in clinical decision-making, including dose selection and biomarker identification.
• In April 2024, the FDA announced the establishment of the Center for Clinical Trial Innovation (C3TI). This center aims to promote innovative approaches to clinical trials, improving the efficiency of drug development through enhanced communication and collaboration within the FDA and with external stakeholders.
• In January 2024, the FDA approved Darmiyan's BrainSee, an AI-based software platform that predicts the progression of amnestic mild cognitive impairment (aMCI) to Alzheimer's disease. This tool combines brain MRI and cognitive assessments to generate an objective score, aiding in early intervention strategies.

To read more about the latest highlights related to the bioinformatics market, get a snapshot of the key highlights entailed in the global bioinformatics market report here https://www.delveinsight.com/report-store/bioinformatics-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=jpr

Bioinformatics Overview
Bioinformatics is an interdisciplinary field that combines biology, computer science, mathematics, and statistics to analyze and interpret complex biological data. It plays a crucial role in managing and understanding large-scale genomic and proteomic datasets generated by high-throughput technologies like next-generation sequencing (NGS). By leveraging computational tools and algorithms, bioinformatics enables researchers to uncover insights into gene function, disease mechanisms, and drug responses, ultimately advancing areas such as personalized medicine, drug discovery, and diagnostics. As the volume of biological data continues to grow, bioinformatics is becoming increasingly essential in transforming raw data into actionable biomedical knowledge.

Bioinformatics Market Insights
North America is expected to dominate the global bioinformatics market, driven by the growing adoption of advanced technologies, the rising demand for personalized medicine, and the development of innovative bioinformatics software. The region's experience with the COVID-19 pandemic has further accelerated the need for robust bioinformatics solutions. For example, the United States reported over 79 million COVID-19 cases, with more than 960,000 related deaths by 2021, according to the CDC-highlighting the critical role of bioinformatics in managing public health crises.

In addition, ongoing technological advancements continue to fuel market growth. A notable example is the March 2022 launch of Rio by ARUP Laboratories-a next-generation bioinformatics platform designed to enhance cloud computing capabilities, enabling faster and more accurate sequencing test results. Such innovations are streamlining clinical workflows and supporting improved decision-making in patient care.

These factors collectively position North America, particularly the U.S., as a key growth driver in the global bioinformatics market.

To know more about why North America is leading the market growth in the bioinformatics market, get a snapshot of the bioinformatics market outlook here https://www.delveinsight.com/report-store/bioinformatics-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=jpr

Bioinformatics Market Dynamics
The bioinformatics market is experiencing growing product demand, primarily driven by the increasing need for nucleic acid and protein sequencing. Protein sequencing enables researchers to determine amino acid sequences and identify post-translational modifications, while DNA sequencing uncovers the precise order of nucleotides-adenine, guanine, cytosine, and thymine-in DNA strands. This surge in demand is further supported by the introduction of innovative tools like DNAnexus Apollo and DNAnexus Titan by DNANEXUS INC., which accelerate precision drug discovery by integrating omics and clinical data analysis in a scalable, cloud-based environment.

These advanced platforms are enhancing disease prevention, diagnosis, and treatment by enabling researchers and clinicians to conduct comprehensive studies within a unified framework. Additionally, the urgency brought on by the COVID-19 pandemic has significantly increased the need for rapid development of new treatments and vaccines, reinforcing the critical role of bioinformatics in global health.

As a result, the expanding applications of sequencing technologies and the push for personalized medicine are expected to propel the bioinformatics market forward. However, the high costs associated with bioinformatics tools and services, along with a shortage of skilled professionals, could pose challenges to market growth. Nevertheless, the pandemic underscored the value of bioinformatics in understanding and combating infectious diseases, presenting new growth opportunities for the industry.

Get a sneak peek at the bioinformatics market dynamics @ https://www.delveinsight.com/report-store/bioinformatics-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=jpr

Coverage: Global
Study Period: 2022 to 2032
Bioinformatics Market CAGR: ~15.14%
Key Bioinformatics Companies: Agilent Technologies, Biomax Informatics AG, DNANEXUS, INC., Thermo Fisher Scientific, Inc., Eurofins Scientific, QIAGEN N.V., Illumina Inc., NeoGenomics Laboratories, Rosalind Inc., Perkin Elmer, Inc., GENEWIZ, BGI Corporation, and others.

Bioinformatics Market Segmentation
Market Segmentation By Product Type: Bioinformatics Products, Bioinformatics Services.
Market Segmentation By Bioinformatics Products: Knowledge Management Tools, Bioinformatics Platforms.
Market Segmentation By Application: Genomics, Proteomics, Transcriptomics, others.
Market Segmentation By Sector: Medical Bioinformatics, Animal Bioinformatics, Agriculture Bioinformatics, others.
Market Segmentation By Geography: North America, Europe, Asia-Pacific, and Rest of the World.

Which MedTech key players in the bioinformatics market are set to emerge as the trendsetter, explore @ https://www.delveinsight.com/report-store/bioinformatics-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=jpr

Table of Contents
1. Bioinformatics Market Report Introduction
2. Bioinformatics Market Executive Summary
3. Competitive Landscape
4. Regulatory Analysis
5. Bioinformatics Market Key Factors Analysis
6. Bioinformatics Market Porter's Five Forces Analysis
7. Bioinformatics Market Layout
8. Bioinformatics Market Company and Product Profiles
9. KOL Views
10. Project Approach
11. About DelveInsight
12. Disclaimer & Contact Us

Contact Us:
Jatin Vimal
jvimal@delveinsight.com
+14699457679
Healthcare Consulting
https://www.delveinsight.com/consulting-services

About DelveInsight
DelveInsight is a premier healthcare business consultant and market research firm, specializing in life sciences. We empower pharmaceutical companies with comprehensive end-to-end solutions designed to enhance performance and drive growth.

Our expert healthcare consulting services offer in-depth market analysis, helping businesses accelerate growth and navigate challenges with actionable, results-driven strategies.

This release was published on openPR.